Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | ||||
| Current Assets | ||||
| Receivables | 1 | N/A | N/A | N/A |
| Inventories | 210 | N/A | N/A | N/A |
| Other current assets | 61 | 0 | 0 | 0 |
| TOTAL | $380 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 500 | N/A | N/A | N/A |
| Intangibles | 1,696 | 0 | 0 | 0 |
| Other Non-Current Assets | 94 | 0 | 0 | 0 |
| TOTAL | $2,290 | $N/A | $N/A | $N/A |
| Total Assets | $2,540 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 20 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 150 | 0 | 0 | 0 |
| Accrued Expenses | 100 | N/A | N/A | N/A |
| Other current liabilities | 510 | N/A | N/A | N/A |
| TOTAL | $840 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 490 | N/A | N/A | N/A |
| Deferred Revenues | 58 | N/A | N/A | N/A |
| TOTAL | $490 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,330 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | N/A | N/A | N/A |
| Retained earnings | -11,840 | N/A | N/A | N/A |
| Other shareholders' equity | -1,071 | 0 | 0 | 0 |
| TOTAL | $1,200 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $2,530 | $0 | $0 | $0 |